Medical Treatments Patient Care Clinical Trials Clinical Research Medical Research Pharmaceuticals Neurology Oncology Cancer Pharmacology
The Fujirebio Lumipulse test offers a less invasive, cost-effective method for detecting beta-amyloid plaques in symptomatic adults aged 55 and older.